Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giannakis

Showing results (441-450 of 518) with videos related to

Pageof 52
Sort By:
The Oncologist|February 22, 2023
Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic CancerKimberly Perez, Anna M Chiarella, James M Cleary, et al.
Cancer Discovery|August 9, 2024
Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal CancersPatrick Loi, Amy E Schade, Carrie L Rodriguez, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2018
Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumourTsuyoshi Hamada, Li Liu, Jonathan A Nowak, et al.
AIDS Care|March 29, 2021
Characterization of people living with HIV in a Montreal-based tertiary care center with COVID-19 during the first wave of the pandemicDerek Fehr, Bertrand Lebouché, Luciana Ruppenthal, et al.
The Science of the Total Environment|June 13, 2018
What is socio-ecological research delivering? A literature survey across 25 international LTSER platformsJan Dick, Daniel E Orenstein, Jennifer M Holzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2020
Prognostic Significance of Immune Cell Populations Identified by Machine Learning in Colorectal Cancer Using Routine Hematoxylin and Eosin-Stained SectionsJuha P Väyrynen, Mai Chan Lau, Koichiro Haruki, et al.
Journal for Immunotherapy of Cancer|May 1, 2021
Prognostic significance of myeloid immune cells and their spatial distribution in the colorectal cancer microenvironmentJuha P Väyrynen, Koichiro Haruki, Sara A Väyrynen, et al.
Science (New York, N.Y.)|January 6, 2018
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinomaDiana Miao, Claire A Margolis, Wenhua Gao, et al.
European Journal of Cancer (Oxford, England : 1990)|March 4, 2019
Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trialKeisuke Kosumi, Tsuyoshi Hamada, Sui Zhang, et al.
JCO Precision Oncology|June 21, 2023
Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With GI CancerHarshabad Singh, Samuel J Klempner, Nelya Melnitchouk, et al.
Pageof 52

Showing results (441-450 of 518) with videos related to

Sort By:
Pageof 52
The Oncologist|February 22, 2023
Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic CancerKimberly Perez, Anna M Chiarella, James M Cleary, et al.
Cancer Discovery|August 9, 2024
Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal CancersPatrick Loi, Amy E Schade, Carrie L Rodriguez, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2018
Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumourTsuyoshi Hamada, Li Liu, Jonathan A Nowak, et al.
AIDS Care|March 29, 2021
Characterization of people living with HIV in a Montreal-based tertiary care center with COVID-19 during the first wave of the pandemicDerek Fehr, Bertrand Lebouché, Luciana Ruppenthal, et al.
The Science of the Total Environment|June 13, 2018
What is socio-ecological research delivering? A literature survey across 25 international LTSER platformsJan Dick, Daniel E Orenstein, Jennifer M Holzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2020
Prognostic Significance of Immune Cell Populations Identified by Machine Learning in Colorectal Cancer Using Routine Hematoxylin and Eosin-Stained SectionsJuha P Väyrynen, Mai Chan Lau, Koichiro Haruki, et al.
Journal for Immunotherapy of Cancer|May 1, 2021
Prognostic significance of myeloid immune cells and their spatial distribution in the colorectal cancer microenvironmentJuha P Väyrynen, Koichiro Haruki, Sara A Väyrynen, et al.
Science (New York, N.Y.)|January 6, 2018
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinomaDiana Miao, Claire A Margolis, Wenhua Gao, et al.
European Journal of Cancer (Oxford, England : 1990)|March 4, 2019
Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trialKeisuke Kosumi, Tsuyoshi Hamada, Sui Zhang, et al.
JCO Precision Oncology|June 21, 2023
Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With GI CancerHarshabad Singh, Samuel J Klempner, Nelya Melnitchouk, et al.
Pageof 52